Logo image of BON

BON NATURAL LIFE LTD-A (BON) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BON - KYG144922047 - Common Stock

1.7238 USD
+0 (+0.22%)
Last: 1/14/2026, 3:15:12 PM
Fundamental Rating

3

Overall BON gets a fundamental rating of 3 out of 10. We evaluated BON against 82 industry peers in the Chemicals industry. BON has an average financial health and profitability rating. While showing a medium growth rate, BON is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • BON had positive earnings in the past year.
  • BON had a negative operating cash flow in the past year.
  • BON had positive earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: BON reported negative operating cash flow in multiple years.
BON Yearly Net Income VS EBIT VS OCF VS FCFBON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

  • BON has a Return On Assets (0.81%) which is comparable to the rest of the industry.
  • BON has a Return On Equity (1.08%) which is comparable to the rest of the industry.
  • BON's Return On Invested Capital of 2.23% is on the low side compared to the rest of the industry. BON is outperformed by 65.85% of its industry peers.
  • BON had an Average Return On Invested Capital over the past 3 years of 8.52%. This is above the industry average of 6.10%.
  • The 3 year average ROIC (8.52%) for BON is well above the current ROIC(2.23%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.81%
ROE 1.08%
ROIC 2.23%
ROA(3y)9.09%
ROA(5y)10.38%
ROE(3y)11.65%
ROE(5y)16.28%
ROIC(3y)8.52%
ROIC(5y)10.57%
BON Yearly ROA, ROE, ROICBON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • The Profit Margin of BON (2.67%) is better than 60.98% of its industry peers.
  • In the last couple of years the Profit Margin of BON has declined.
  • With a Operating Margin value of 9.59%, BON perfoms like the industry average, outperforming 54.88% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BON has declined.
  • BON has a Gross Margin (27.99%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of BON has declined.
Industry RankSector Rank
OM 9.59%
PM (TTM) 2.67%
GM 27.99%
OM growth 3Y-28.15%
OM growth 5Y-16.51%
PM growth 3Y-54.74%
PM growth 5Y-36.12%
GM growth 3Y2.25%
GM growth 5Y-1.53%
BON Yearly Profit, Operating, Gross MarginsBON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BON is destroying value.
  • The number of shares outstanding for BON has been increased compared to 1 year ago.
  • BON has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BON has a worse debt to assets ratio.
BON Yearly Shares OutstandingBON Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50K 100K 150K
BON Yearly Total Debt VS Total AssetsBON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 1.47, we must say that BON is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.47, BON is not doing good in the industry: 65.85% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.15 indicates that BON is not too dependend on debt financing.
  • BON has a Debt to Equity ratio of 0.15. This is amongst the best in the industry. BON outperforms 84.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 1.47
ROIC/WACC0.23
WACC9.74%
BON Yearly LT Debt VS Equity VS FCFBON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

  • BON has a Current Ratio of 2.44. This indicates that BON is financially healthy and has no problem in meeting its short term obligations.
  • BON has a better Current ratio (2.44) than 69.51% of its industry peers.
  • A Quick Ratio of 2.29 indicates that BON has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 2.29, BON belongs to the best of the industry, outperforming 85.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 2.29
BON Yearly Current Assets VS Current LiabilitesBON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

  • BON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -94.80%.
  • BON shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -44.75% yearly.
  • BON shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.44%.
  • The Revenue has been growing slightly by 7.78% on average over the past years.
EPS 1Y (TTM)-94.8%
EPS 3Y-71.08%
EPS 5Y-44.75%
EPS Q2Q%346.26%
Revenue 1Y (TTM)-15.44%
Revenue growth 3Y-2.21%
Revenue growth 5Y7.78%
Sales Q2Q%-21.93%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue is expected to grow by 24.08% on average over the next years. This is a very strong growth
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year77.63%
Revenue Next 2Y45.28%
Revenue Next 3Y34.64%
Revenue Next 5Y24.08%

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BON Yearly Revenue VS EstimatesBON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M 100M
BON Yearly EPS VS EstimatesBON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 50 100 150

2

4. Valuation

4.1 Price/Earnings Ratio

  • BON is valuated cheaply with a Price/Earnings ratio of 0.51.
  • Compared to the rest of the industry, the Price/Earnings ratio of BON indicates a rather cheap valuation: BON is cheaper than 100.00% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.30. BON is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 0.51
Fwd PE N/A
BON Price Earnings VS Forward Price EarningsBON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.25
BON Per share dataBON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for BON!.
Industry RankSector Rank
Dividend Yield 0%

BON NATURAL LIFE LTD-A

NASDAQ:BON (1/14/2026, 3:15:12 PM)

1.7238

+0 (+0.22%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)09-25
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap6.98M
Revenue(TTM)21.61M
Net Income(TTM)577.90K
Analysts0
Price TargetN/A
Short Float %0.34%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.51
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 0.13
P/tB 0.13
EV/EBITDA -0.25
EPS(TTM)3.4
EY197.24%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.5
FCFYN/A
OCF(TTM)-2.5
OCFYN/A
SpS5.34
BVpS13.22
TBVpS13.03
PEG (NY)N/A
PEG (5Y)N/A
Graham Number31.8
Profitability
Industry RankSector Rank
ROA 0.81%
ROE 1.08%
ROCE 3.83%
ROIC 2.23%
ROICexc 2.61%
ROICexgc 2.64%
OM 9.59%
PM (TTM) 2.67%
GM 27.99%
FCFM N/A
ROA(3y)9.09%
ROA(5y)10.38%
ROE(3y)11.65%
ROE(5y)16.28%
ROIC(3y)8.52%
ROIC(5y)10.57%
ROICexc(3y)8.65%
ROICexc(5y)11.01%
ROICexgc(3y)8.8%
ROICexgc(5y)11.18%
ROCE(3y)13.84%
ROCE(5y)17.18%
ROICexgc growth 3Y-44.37%
ROICexgc growth 5Y-33.89%
ROICexc growth 3Y-44.35%
ROICexc growth 5Y-33.92%
OM growth 3Y-28.15%
OM growth 5Y-16.51%
PM growth 3Y-54.74%
PM growth 5Y-36.12%
GM growth 3Y2.25%
GM growth 5Y-1.53%
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA 2.53
Cap/Depr 0.62%
Cap/Sales 0.03%
Interest Coverage 6.4
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 2.29
Altman-Z 1.47
F-Score4
WACC9.74%
ROIC/WACC0.23
Cap/Depr(3y)764.29%
Cap/Depr(5y)1250.29%
Cap/Sales(3y)6.63%
Cap/Sales(5y)12.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.8%
EPS 3Y-71.08%
EPS 5Y-44.75%
EPS Q2Q%346.26%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.44%
Revenue growth 3Y-2.21%
Revenue growth 5Y7.78%
Sales Q2Q%-21.93%
Revenue Next Year77.63%
Revenue Next 2Y45.28%
Revenue Next 3Y34.64%
Revenue Next 5Y24.08%
EBIT growth 1Y-31.3%
EBIT growth 3Y-29.74%
EBIT growth 5Y-10.01%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-198.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-353.53%
OCF growth 3YN/A
OCF growth 5YN/A

BON NATURAL LIFE LTD-A / BON FAQ

Can you provide the ChartMill fundamental rating for BON NATURAL LIFE LTD-A?

ChartMill assigns a fundamental rating of 3 / 10 to BON.


Can you provide the valuation status for BON NATURAL LIFE LTD-A?

ChartMill assigns a valuation rating of 2 / 10 to BON NATURAL LIFE LTD-A (BON). This can be considered as Overvalued.


How profitable is BON NATURAL LIFE LTD-A (BON) stock?

BON NATURAL LIFE LTD-A (BON) has a profitability rating of 4 / 10.